Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

GSK Launches Tackle Meningitis Campaign with Matt Dawson to Raise Awareness of the Symptoms of Disease


News provided by

GSK

15 Sep, 2016, 23:01 GMT

Share this article

Share toX

Share this article

Share toX

LONDON, September 16, 2016 /PRNewswire/ --

GSK has today announced the launch of the Tackle Meningitis campaign in partnership with former England Rugby player, Matt Dawson, an initiative aimed at raising awareness of meningitis, which is a rare but potentially fatal disease. The campaign is also backed by UK charities Meningitis Research Foundation and Meningitis Now.

Tackle Meningitis aims to increase understanding of the disease, its symptoms and the fact that there are different strains of meningitis that can affect both children and young people, using the influence of sport and teamwork to reach as many people as possible.

With the peak season for meningitis just around the corner,[1] the campaign will raise awareness of existing information and materials that can be used to help spot suspected cases of meningitis, as well as undertaking a nationwide survey to assess how much people know about the disease and to highlight any information gaps. The results of the survey, which will be announced later in the year, will be used to guide the direction of the Tackle Meningitis campaign throughout 2017 engaging with schools, rugby clubs and community organisations.

Matt Dawson has first-hand experience of meningitis after his two-year old son, Sami, contracted meningitis in February this year and remained critically ill on a life-support machine for two weeks afterwards. Sami subsequently recovered from the disease and Matt now wants parents and families to receive the knowledge and education that he feels he lacked.

Matt said: "I wish I had known more about meningitis and what to look out for. People only think of the glass test, but there are other lesser known symptoms that it's very important to be aware of. In truth, I was fairly ignorant about how dangerous it can be, but thankfully we turned out to be incredibly lucky. With this disease, even a matter of minutes can make a huge difference to the outcome.

"I feel passionate about standing behind a campaign which uses the power and influence of sport and its ability to reach people of all ages. Together we can tackle meningitis to give families the best fighting chance against this devastating disease."

Vinny Smith, Meningitis Research Foundation Chief Executive, said: "Meningitis is a devastating disease that can kill or cause disability in a matter of hours. Amongst those most at risk are babies, children and young people, but anyone can be affected.

"Knowing the signs, symptoms and steps to take is crucial in order to act fast and improve outcomes, and this is what we will be working towards during next week's Meningitis Awareness Week. Our hope is that campaigns like Tackle Meningitis will generate a real shift in the way parents and families think about and act towards meningitis and septicaemia."

Liz Brown, Chief Executive at Meningitis Now commented: "We welcome GSK's efforts to drive up levels of awareness of meningitis and applaud Matt Dawson's courage in using his experience of the disease to help save lives.

With 30 years' experience of fighting this disease, we know how important the awareness message is, having shared 1.3 million free signs and symptoms cards last year alone and provided clear and accurate information for more people than ever before. As parents like Matt Dawson have found, early symptoms of the disease can be overlooked, with in some cases, devastating consequences.  We are particularly excited to see how 'Tackle Meningitis' utilises sport to reach those who still don't know about the disease."

Symptoms of meningitis can develop rapidly. The first symptoms are usually fever, vomiting, headache and feeling unwell. Limb pain, pale skin, and cold hands and feet often appear earlier than the rash (which doesn't fade when a glass is rolled over it), neck stiffness, dislike of bright lights and confusion. Although a rash is often the most well-known symptom, it is often a sign that the disease is advancing rapidly and it is therefore crucial not to wait to for it to appear before seeking medical attention.

Notes to editors 

About meningitis and septicaemia 

Meningitis is the inflammation of the lining around the brain and spinal cord (meninges).[2] It can be very serious if not treated quickly, with the potential to cause life-threatening blood poisoning (septicaemia), permanent damage to the brain or nerves, loss of limbs and in some cases, death.[1] In the early stages of the disease it can be very difficult to tell meningitis and septicaemia apart from milder diseases, as they often resemble common viral illnesses.[3]

There are several types, or strains, of meningococcal bacteria with the main groups being A, B, C, W, X, and Y[4] and although group B meningococcal causes the majority of disease in the UK,[5] all of the meningococcal bacteria strains can be fatal. Vaccines are available to protect against some of the strains,[1] however, no single vaccine protects against all strains.[6] Meningitis and septicaemia can kill in hours, making it vital to be aware of the symptoms and act accordingly.[7] If you suspect someone may have meningitis or septicaemia you need to trust your instincts and seek the nearest medical help immediately.[3]

About Meningitis Research Foundation 

Meningitis Research Foundation (MRF) is a UK-based charity that aims to raise awareness of meningitis and septicaemia and provide support to all those affected by the two diseases. A key aspect of their work involves funding research into the prevention, detection and treatment of meningitis and septicaemia and sharing the knowledge gained by research so everyone can benefit. The charity currently funds 16 research projects throughout the world, and since its foundation in 1989, it has awarded 147 research grants, leading to many advances in the prevention, detection and treatment of meningitis and septicaemia.

About Meningitis Now 

Meningitis Now is a charity with almost 30 years' experience. The charity was formed in 2013 by bringing together Meningitis UK and Meningitis Trust, founders of the meningitis movement in the UK. They fund research into vaccines and prevention and aim to reduce the impact of the disease by raising awareness and providing people with the knowledge and information they need to get urgent medical attention if they suspect meningitis. A large part of their work also goes into rebuilding futures by providing dedicated support to people living with the impact of meningitis.

Both Meningitis Research Foundation and Meningitis Now back the Tackle Meningitis campaign, but will continue to run their own campaigns separately.

GSK - one of the world's leading research-based pharmaceutical and healthcare companies - is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For further information please visit http://www.gsk.com.

Cautionary statement regarding forward-looking statements
GSK cautions investors that any forward-looking statements or projections made by GSK, including those made in this announcement, are subject to risks and uncertainties that may cause actual results to differ materially from those projected. Such factors include, but are not limited to, those described under Item 3.D 'Risk factors' in the company's Annual Report on Form 20-F for 2015.

References 

1. Meningitis Research Foundation. Meningitis and septicaemia: UK facts and figures, http://www.meningitis.org/facts  Last accessed September 2016 

2. Meningitis Now. What is meningitis. https://www.meningitisnow.org/meningitis-explained/what-meningitis/   

3. Meningitis Research Foundation. Frequently asked questions. http://www.meningitis.org/disease-info/faqs Last accessed August 2016 

4. NHS Choices. Causes of meningitis. http://www.nhs.uk/Conditions/Meningitis/Pages/Causes.aspx Last accessed August 2016 

5. Meningitis Now. Meningococcal disease https://www.meningitisnow.org/meningitis-explained/what-meningitis/types-and-causes/meningococcal-disease/  Last accessed August 2016 

6. Meningitis Now. Bacterial meningitis https://www.meningitisnow.org/meningitis-explained/what-meningitis/types-and-causes/bacterial-meningitis/ Last accessed August 2016 

7. Meningitis Research Foundation. Meningitis symptoms http://www.meningitis.org/symptoms Last accessed August 2016

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.